Exfoliation Glaucoma – Causes, Symptoms and Treatment
Exfoliation glaucoma is a form of glaucoma in which protein fiber deposits in the eye raise intraocular pressure, progressively damaging the optic nerve.
Things worth knowing about "Exfoliation Glaucoma"
Exfoliation glaucoma is a form of glaucoma in which protein fiber deposits in the eye raise intraocular pressure, progressively damaging the optic nerve.
What is Exfoliation Glaucoma?
Exfoliation glaucoma – also known as pseudoexfoliation glaucoma or PEX glaucoma – is a specific type of glaucoma that develops as a complication of pseudoexfoliation syndrome (PEX syndrome). In this condition, a characteristic whitish-grey fibrillar material accumulates on the lens capsule and in the trabecular meshwork of the eye. This material obstructs the drainage of aqueous humor, leading to an increase in intraocular pressure (IOP). Over time, elevated IOP damages the optic nerve and can result in irreversible vision loss or blindness if left untreated.
Causes and Risk Factors
The exact cause of exfoliation glaucoma is not yet fully understood. A combination of genetic and environmental factors is believed to contribute.
- Genetic predisposition: Variants in the LOXL1 gene – involved in connective tissue formation – are the most significant known genetic risk factor.
- Age: The risk increases significantly with advancing age. The condition is rarely seen before age 60.
- Geographic and ethnic factors: PEX syndrome is particularly prevalent in Scandinavia, the Mediterranean region, and certain Asian populations.
- UV radiation: Increased sun exposure has been proposed as a potential environmental trigger.
- Sex: Women appear to be slightly more affected than men.
Symptoms
Exfoliation glaucoma typically develops gradually and causes no noticeable symptoms in its early stages. Signs in more advanced disease include:
- Visual field loss, often starting at the periphery
- Blurred vision or reduced visual acuity
- In acute pressure spikes: eye pain, headache, nausea, and halos around lights
Because the disease can remain silent for years, it is often diagnosed incidentally during a routine eye examination.
Diagnosis
Diagnosis is made by an ophthalmologist using a combination of tests:
- Slit-lamp examination: Detection of characteristic fibrillar deposits on the lens and in the trabecular meshwork
- Tonometry: Measurement of intraocular pressure
- Gonioscopy: Evaluation of the drainage angle and identification of exfoliative material
- Ophthalmoscopy: Assessment of the optic nerve head for glaucomatous damage (e.g., increased cup-to-disc ratio)
- Perimetry (visual field testing): Detection of visual field defects
- OCT (Optical Coherence Tomography): Structural imaging of the retinal nerve fiber layer
Treatment
The goal of treatment is to lower intraocular pressure and prevent further optic nerve damage. Exfoliation glaucoma often responds less predictably to therapy than primary open-angle glaucoma and may require more intensive management.
Medical Therapy
Treatment typically begins with pressure-lowering eye drops. Drug classes used include:
- Prostaglandin analogues (e.g., latanoprost, bimatoprost): Increase aqueous outflow
- Beta-blockers (e.g., timolol): Reduce aqueous humor production
- Carbonic anhydrase inhibitors (e.g., dorzolamide): Decrease aqueous production
- Alpha-2 agonists (e.g., brimonidine): Dual mechanism of action
Laser Treatment
Selective Laser Trabeculoplasty (SLT) can enhance aqueous drainage through the trabecular meshwork and effectively reduce IOP. It is considered a particularly valuable option in the management of exfoliation glaucoma.
Surgical Treatment
When medications and laser therapy are insufficient, surgical procedures may be considered:
- Trabeculectomy: Creation of a new drainage pathway for aqueous humor
- Minimally invasive glaucoma surgery (MIGS): Micro-incisional procedures with a lower risk profile
Prognosis and Follow-Up
Exfoliation glaucoma tends to follow a more aggressive course than primary open-angle glaucoma, with higher and more fluctuating IOP levels. Regular ophthalmological follow-up is therefore essential to monitor disease progression and adjust treatment. When diagnosed early and managed consistently, most patients can preserve functional vision in the long term.
References
- European Glaucoma Society (EGS): Terminology and Guidelines for Glaucoma, 5th Edition, 2020. Available at: https://www.eugs.org
- Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45(4):265-315. PubMed PMID: 11166364.
- Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901-1911. PubMed PMID: 24825645.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryAntiphospholipid Syndrome
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Exfoliation Glaucoma-en